ABBV vs BMY
ABBV 与 BMY 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | ABBVAbbVie Inc. | BMYBRISTOL-MYERS SQUIBB COMPANY |
|---|---|---|
| 市值 | $520.97B | $127.69B |
| 市盈率(TTM) | 83.3 | 13.9 |
| 市净率 | — | 5.46 |
| 市销率 | 8.5x | 2.6x |
| 股息率 | 2.24% | 3.95% |
| 营收 | $61.16B(TTM) | $50.03B(TTM) |
| 营收同比增长 | 8.6% | -0.2% |
| 净利润 | $6.31B(TTM) | $9.24B(TTM) |
| 净利同比增长 | -1.2% | 178.8% |
| 每股收益(稀释) | $3.54(TTM) | $4.51(TTM) |
| 息税前利润率 | 24.6% | 21.8% |
| 净资产收益率 | — | 30.1% |
| 投入资本回报率 | 18.6% | 14.0% |
| 皮氏F值 | — | 7/9 |
| 一年总回报 | +32.0% | +42.3% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:ABBV vs BMY
| 指标 | ABBV | BMY |
|---|---|---|
| 期末价值 | $73.0K | $12.3K |
| 总回报 | +629.9% | +23.0% |
| 年化收益 (CAGR) | +21.2% | +2.0% |
| 波动率 | 25.8% | 25.4% |
| 夏普比率 | 0.72 | 0.04 |
| 索提诺比率 | 1.00 | 0.06 |
| 最大回撤 | -45.1% | -47.7% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)